Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Henderson's revenue for 2023 grew 35 percent

1/12/24 HNFG

SFI began directly owning its quasi-treasury shares

1/11/24 SFIN

Sollers increased sales by 17% in 2023

1/11/24 SVAV

Severstal may resume dividend payments

1/11/24 CHMF

More than half of TGC-2 shares were transferred to Rosimushchestvo

1/11/24 TGKB

Phosagro increased the capacity of the Balakovo branch of Apatit

1/11/24 PHOR

Cost of CHPP-2 modernization almost tripled in 5 years

1/11/24 HYDR

SPB Exchange wants to liquidate its board of directors

1/11/24 SPBE

SPB Bank submitted an asset unlocking strategy to OFAC

1/11/24 SPBE

Moscow Exchange summarized the results of trading in 2023

1/10/24 MOEX